Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists

Peter Wang; Qilong Yi; Linda Scully; Jenny Heathcote; Murray Krahn

doi:10.1155/2003/498120

Canadian Journal of Gastroenterology (Jan 2003)

Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists

Peter Wang,
Qilong Yi,
Linda Scully,
Jenny Heathcote,
Murray Krahn

Affiliations

Peter Wang: The Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
Qilong Yi: Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Linda Scully: Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
Jenny Heathcote: Division of Gastroenterology, The Ottawa Hospital, Ottawa, Ontario, Canada
Murray Krahn: The Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

DOI: https://doi.org/10.1155/2003/498120
Journal volume & issue: Vol. 17, no. 3
pp. 183 – 186

Abstract

Read online

OBJECTIVE: To survey practising hepatologists about their attitudes and practices regarding interferon and ribavirin combination therapy for hepatitis C (HCV) patients in Canada.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal